Modern stabilized stannous fluoride: A new era in gingival health through advanced plaque prevention

The evolution of stabilized stannous fluoride (SnF2) technology has reshaped the clinical landscape of gingival health management. Earlier stannous fluoride dentifrices were limited by instability and tooth staining issues, but modern stabilization methods have improved antimicrobial efficacy with improved patient experiences and outcomes—changes that provide clinical benefits in reducing gingivitis by altering the anaerobic microbial metabolism of the microbiota.^1,4-6

Why plaque prevention matters 

Plaque biofilm is a primary predecessor of gingival inflammation; even with good brushing, biofilm reforms within hours. A stannous fluoride dentifrice inhibits early plaque reformation, leading to its gingival health benefits between dental hygiene recall visits.¹ Stabilized stannous fluoride maintains bioavailable stannous ions for antimicrobial activity and is retained in the gingival plaque that contributes to a reduction in plaque virulence and gingival health benefits.^4-6  

Evidence from a 14‑day randomized plaque‑prevention study 

Because plaque rapidly re-forms after prophylaxis—especially at the gingival margin—effective plaque prevention is critical for patients. Clinical evidence shows stabilized stannous fluoride toothpaste significantly limits overnight plaque regrowth compared toNaF toothpaste. In a double‑blind, randomized, stratified, parallel‑group clinical trial, adults used either TheraBreath Healthy Gums (stannous fluoride) or regular NaF toothpaste twice daily for 14 days. 

Plaque was measured after ~12 hours without brushing using the Turesky‑Modified Quigley‑Hein Plaque Index (TMQHPI). Compared to NaF, TheraBreath resulted in 65% less whole‑mouth plaque after the first day and 32% less at day 14. The hard‑to‑reach sites also demonstrated plaque reductions ranging from 61–78% at day one and 23–53% at day 14 compared to the control NaF toothpaste (highly significant at p ≤ 0.001).¹ 

Clinical interpretation 

The rapid day one effect supports immediate antimicrobial suppression of early-stage biofilm, while the day 14 result shows sustained benefit under routine use. The greater plaque control efficacy in the hard-to-clean areas is clinically meaningful because these surfaces frequently correspond to bleeding on probing and early attachment loss changes.¹

Staining: From historical concern to modern formulation control 

Historically, stannous fluoride toothpaste was associated with extrinsic tooth staining and taste alteration, largely related to oxidation of Sn2+ to Sn4+ and interactions with chromogens. Contemporary literature confirms that stabilized stannous fluoride systems (e.g., those that include zinc phosphate and polyphosphates) can mitigate staining and, in some trials, actively remove extrinsic stain deposits compared with regular fluoride dentifrices.^4,6-8 

TheraBreath Healthy Gums Toothpaste is formulated with stannous fluoride and polyphosphates (e.g., pentasodium triphosphate) to help prevent staining. This is a silica‑based system commonly used to manage both extrinsic tooth stain and calculusdeposits.

Why plaque prevention matters 

• It enhances home‑care plaque control efforts and adds antimicrobial suppression where technique falters.¹ 

• Prioritizes high‑risk groups (orthodontic patients, those with crowding or dexterity limits, or rapid plaque regrowth). 

• Supports periodontal maintenance; reducing overnight plaque regrowth helps maintain stability between professional therapy.¹ 

• Delivers plaque prevention with stain‑management strategies.^4-7 

Modern stabilized stannous fluoride dentifrices represent a significant advancement in the effort to improve the daily oral hygiene regimen. Combined with formulation approaches intended to mitigate staining, clinicians can recommend this stannous fluoride toothpaste to help maintain gingival health between visits.

Editor's note: The article appeared in the April/May 2026 print edition of RDH magazine. Dental hygienists in North America are eligible for a complimentary print subscription. Sign up here.

References: 

1. IADR abstract – C&D plaque prevention study Final 09‑29‑2025: New Stannous Fluoride Toothpaste Actively Prevents Dental Plaque Accumulation (double‑blind, randomized, 14‑day TMQHPI outcomes).

2. TheraBreath Healthy Gums: cetylpyridinium chloride rinse. DailyMed. Updated December 3, 2025.  https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e06bfc9e-38e5-475b-89c1-026ccfe56031

3. Q&A on the new TheraBreath toothpaste–what you need to know. Dentistry Today. February 13, 2026.  https://www.dentistrytoday.com/qa-on-the-new-therabreath-toothpaste-what-you-need-to-know/  

4. Li Y, Suprono M, Mateo LR, et al.  Solving the problem with stannous fluoride: extrinsic stain. J Am Dent Assoc. 2019;150(4S):S38-S46. doi:10.1016/j.adaj.2019.01.002

5. Shearer B. Unlocking the key to stabilized stannous fluoride toothpaste. Dental Products Report. May 21, 2019.

6. Klukowska MA, Ramji N, Combs C, et al. Subgingival uptake and retention of stannous fluoride from dentifrice: Gingival crevicular fluid concentration in sulci post-brushing. Am J Dent. 2018;31(4):184-188.

7. Elías‑Boneta AR, Mateo LR, et al. Efficacy of a novel stannous fluoride toothpaste stabilized with nitrate and phosphates (SNaP) in extrinsic tooth stain removal: a randomized controlled trial. Compend Contin Educ Dent. 2024;45(Suppl 3):46-52.

8. Stannous fluoride toothpaste benefit: anti‐stain and whitening. Dentalcare.  https://www.dentalcare.com/en-us/stannous-fluoride/oral-health/anti-stain-and-whitening